Inventor · disambiguated record
Eriko Nakata
Also filed as: NAKATA ERIKO
7 granted patents·5 pending applications·21 citations·filing 2008–2024
80Inventor score
Top patents by PatentIndex Score
12 records- 0189US12109209B2Use of morphinan derivatives for treatment of opioid delta receptor agonist-related diseaseNIPPON CHEMIPHAR CO·Filed 2022·Granted Oct 8, 2024·1 cites·9 claims
- 0286US9624223B2Morphinan derivativeTHE KITASATO INST·Filed 2013·Granted Apr 18, 2017·6 cites·22 claims
- 0382US10442802B2Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2016·Granted Oct 15, 2019·4 cites·83 claims
- 0482US8952030B2Morphinan derivativeNAGASE HIROSHI·Filed 2012·Granted Feb 10, 2015·9 cites·30 claims
- 0580US11633392B2Use of morphinan derivative for therapeutic treatment of opioid delta receptor agonist-related diseaseNIPPON CHEMIPHAR CO·Filed 2017·Granted Apr 25, 2023·1 cites·14 claims
- 0676US2024374583A1Use of morphinan derivatives for treatment of opioid delta receptor agonist-related diseaseNIPPON CHEMIPHAR CO·Filed 2024·Application pending·0 cites
- 0776US2023159530A1Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2023·Application pending·0 cites
- 0868US10995092B2Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2019·Granted May 4, 2021·0 cites·1 claims
- 0967US11643411B2Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2020·Granted May 9, 2023·0 cites·20 claims
- 1057US2024156796A1Pharmaceutical composition for treatment or prevention of stress-related disordersUNIV TOKYO SCIENCE FOUND·Filed 2022·Application pending·0 cites
- 1147US2011092703A1P2x4 receptor antagonistNIPPON CHEMIPHAR CO·Filed 2008·Application pending·0 cites
- 1238US2021371422A1Morphinan derivativeNIPPON CHEMIPHAR CO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Eriko Nakata files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →